Propelled by the growing prevalence
of cancer and huge funding for regenerative medicines by the federal
government, the global bone marrow transplant market is expected to rise with a
CAGR of 5.45% over the forecast period of 2018-2026.
To know more about the latest trends, analysis on the Global Bone Marrow Transplant market, request a free sample copy
MARKET
INSIGHTS
The global bone marrow transplant market is segmented on the
basis of end-users, indications and transplant type. The end-users for this market are hospitals, multi-specialty
clinics and ambulatory surgical centres. The indications segment of the bone
marrow transplant market includes acute
leukaemia, multiple myelomas, Hodgkin
lymphoma, Non-Hodgkin lymphoma, solid tumours
and other indications. The market
by transplant type is segmented into
allogenic bone marrow transplant and autologous bone marrow transplant.
REGIONAL
INSIGHTS
The regional segmentation of
the global bone marrow transplant market is done into Europe, Asia-Pacific, North America and rest of the world. The
Asia-Pacific bone marrow transplant
market is anticipated to progress with
the fastest CAGR over the forecast period. Growing investments in public and private sectors to cater to the
needs of the medical needs of the ever-growing
population in China and India are contributing to the market growth in this region. However, a major chunk of the global
market share is expected to be captured by the
European bone marrow transplant market. The region is witnessing increasing
cases of breast, prostate and colorectal cancer. Also, the government in UK and
Spain are encouraging proactive policies to increase the market demand in this
region.
COMPETITIVE INSIGHTS
Some of the key companies engaged
in the bone marrow transplant market are Affymetrix Inc. (Acquired By Thermofisher), Abbott Laboratories, Agendia N.V, Ambrilia Biopharma Inc, Agilent
Technologies Inc, Astellas Pharma Inc, Diadexus Inc. (Acquired By Diazyme
Laboratories), Qiagen N.V, Illumina Inc, Roche Diagnostics Ltd, Sanofi and
Stryker Corporation.

Comments
Post a Comment